13th Annual Eurasian Pharmaceutical Forum

(former EAEU & CIS) The leading forum on EAEU regulation and Eurasian markets

1 - 3 March 2022

Marriott Grand Hotel, Moscow, Russia

Speakers 2022

Marina Durmanova is the President of the Republic of Kazakhstan Pharmaceutical Activity Support and Development Association the participants of which are the national and foreign pharmaceuticals manufacturers, distribution companies and pharmacy organizations. Represented by Marina Durmanova, the Association takes an active part in standard setting process. She is a member of the task groups under the Mazhilis (the lower house) of the Parliament that discuss various draft laws in the public health sphere.

The Association s a member of the Social Council under the Republic of Kazakhstan Public Health Ministry, National Scientific Council operating in the sphere of the life science and health with pharmaceutical science as the priority line, Republic of Kazakhstan Public Health Ministry’s collegium, formulary commission under the RK Public Health Ministry, Expert and Business Council under the Almaty Akimat (City Executive Board). She has been accredited by the Republic of Kazakhstan National Chamber of Entrepreneurs and is a member of the Pharmaceutical and Medical Industry Committee under the RK NCE Atameken.

The Republic of Kazakhstan Pharmaceutical Activity Support and Development Association is a member of the task group in charge of development of general approach to control of pharmaceuticals and medical products circulation within the boundaries of the Customs Union and the Common Economic Area.

Marina Durmanova has repeatedly received state awards for her contribution to development of the national public health sphere.   

Dr. Aleksandr Solodovnikov has 14 years of clinical trial expertise as an  investigator, CRA, clinical operations trial lead and clinical operations manager in fields of Endocrinology, Psychiatry, Cardiology, Pulmonology, Oncology, Hematology, Dermatology, Neurology, Surgery and Infectious Diseases (more than 30 trials, phase I-IV).

Aleksandr graduated from the Ural State Medical Academy (now University) in 2003 and started his scientific career at the Chair of preventative and family medicine resulting in a PhD in Rheumatology in 2009. Dr. Solodovnikov is now an associate professor of this Chair supervising edivence-based medicine and biostatistics fields.  Aleksandr received his training in statistics and epidemiology at the University of Manchester, UK, and at the Erasmus University, the Netherlands, and personally prepared and conducted more than 300 various statistical analyses in various statistical software packages (NCSS, Stata, R, SPSS, Statistica and other) and provided a lot of consultations in this field. He further developed his professional skills in clinical research by taking the “Principles and Practice of Clinical Research” course at Harvard Medical School in 2014. In 2016, Aleksandr also successfully completed the “Project Management Professional”.

Dr. Solodovnikov is a skillful trainer and lecturer, and has conducted numerous GCP trainings as well as seminars in biostatistics, evidence-based medicine, clinical research, drug development and regulations in clinical trials. He knows local, regional (EAEU) and international clinical trial regulations and guidelines well, and took part in the development of hundreds of clinical trial documents for medicines, medical devices, cosmetic and dietary products, and biologically active substances, starting from study concept and ending with the final protocol.